Grant: Discovery Grants Program - Individual
Simon Fraser University
$90,000.00
Nature and origin of carbohydrate mimicry
EF 2012-13
Résumé
A program of research designed to exploit the concept of carbohydrate mimicry is proposed. The concept is of importance because of the need for tighter-binding drugs or more selective vaccine candidates. We have chosen several biologically important targets for the development of drug or vaccine candidates. These include an antibody of importance for the development of a vaccine against dysentry, a critical enzyme (UDP-galactopyranose mutase) necessary for survival of M. tuberculosis (and absent in humans), an enzyme (neuraminidase) critical for the propagation of influenza virus, and an antibody of importance for the development of a vaccine against Group B Streptococcus, the causative agent of meningitis in newborns.
Our approach is based on a detailed knowledge of the interaction between these protein targets and their complementary substrates (ligands). We will study the conformations and topographical features of the small molecule ligands recognized by the antibodies or enzymes of microbial origin. This will require a combined NMR spectroscopy/molecular dynamics protocol, coupled to a quantitative evaluation of the contacts between the ligands and their cognate protein receptors. We propose to develop new experimental and computational methods to generate more reliable models of protein-ligand complexes, and to design new lead drug or vaccine candidates.
We will then synthesize these new lead molecules and test them for their efficacy of binding to their respective protein targets. The collective information will lead to a deeper understanding of the requirements for mimics of carbohydrates that can be used to generate tighter-binding drugs or more selective vaccines, and to a broader understanding of the theories of mimicry and molecular recognition.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
38227-2009
Name nom
Pinto, BrianMario
Department département
Chemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2009
Award amount
90000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
4
Nb partie
5
Application title
Nature and origin of carbohydrate mimicry
Keyword
NSERC
Application summary
A program of research designed to exploit the concept of carbohydrate mimicry is proposed. The concept is of importance because of the need for tighter-binding drugs or more selective vaccine candidates. We have chosen several biologically important targets for the development of drug or vaccine candidates. These include an antibody of importance for the development of a vaccine against dysentry, a critical enzyme (UDP-galactopyranose mutase) necessary for survival of M. tuberculosis (and absent in humans), an enzyme (neuraminidase) critical for the propagation of influenza virus, and an antibody of importance for the development of a vaccine against Group B Streptococcus, the causative agent of meningitis in newborns.
Our approach is based on a detailed knowledge of the interaction between these protein targets and their complementary substrates (ligands). We will study the conformations and topographical features of the small molecule ligands recognized by the antibodies or enzymes of microbial origin. This will require a combined NMR spectroscopy/molecular dynamics protocol, coupled to a quantitative evaluation of the contacts between the ligands and their cognate protein receptors. We propose to develop new experimental and computational methods to generate more reliable models of protein-ligand complexes, and to design new lead drug or vaccine candidates.
We will then synthesize these new lead molecules and test them for their efficacy of binding to their respective protein targets. The collective information will lead to a deeper understanding of the requirements for mimics of carbohydrates that can be used to generate tighter-binding drugs or more selective vaccines, and to a broader understanding of the theories of mimicry and molecular recognition.